LA Investment Firm Helping Chinese Genomics Firm Land US Pharma Deals

May 28, 2004

NEW YORK, May 28 (GenomeWeb News) - NewCap Partners, a Los Angeles-based boutique investment-banking company, is helping Shanghai Genomics forge contract research alliances with US drug makers, according to a report on Forbes.com today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

All So Similar

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A Very Long Time Ago Indeed

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

This Week in PNAS

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Genetic Condition to Drug Inspiration

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Main menu